Intervento chirurgico robotizzato su cancro dell'endometrio
Wiki Oncologia
- Le varianti di un solo gene all’origine dei tumori della pelle e del glioma
- Identificata all’Istituto Gaslini una nuova strategia per il trattamento dei tumori polmonari
- Studio IARC: molti tumori hanno origine dalle infezioni
- Tumore: una patologia sempre più cronica e di massa. Preoccupano le differenze regionali nelle opportunità di cura per i pazienti
- Tumore del seno: “Serve uno screening personalizzato. Mammografia anche alle quarantenni e alle over 70”
- Efficacia della radioterapia intraoperatoria nel carcinoma prostatico
- Una foto dell'epi-genoma per la terapia personalizzata dei tumori
- Nello Zebrafish il modello per colpire Ras, un gene alla base di tumori e malattie genetiche
- Modelli molecolari per predire quale farmaco può meglio funzionare nella cura di alcuni tumori
- Istituto Regina Elena: dalla ricerca di laboratorio una nuova arma per la lotta contro il carcinoma ovarico
Oncologia
|
||||||||||||||||||||
|
||||||||||||||||||||
|
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >> |
||||||||||||||||||||
| Pagina 1 di 660 | ||||||||||||||||||||
Background:Glioblastoma multiforme (GBM) is the most aggressive and frequent brain tumor, albeit without cure. Although patient survival is limited to one year on average, significant variability in outcome is observed. The assessment of biomarkers ... ...
Background:The purpose of our study was to compare differences in the prognosis of breast cancer (BC) patients at high (H) risk or intermediate slightly (IS) increased risk based on family history and those without a family history of BC, and to eva ... ...
Backgound Ovarian cancer still has a relatively poor prognosis due to the frequent occurrence of drug resistance, making the identification of new therapeutic targets an important goal. We have studied the role of HOX genes in the survival and prolif ... ...
Background:Single nucleotide polymorphism (SNP) 309 resulting in a T or G allele in the promoter of MDM2, the negative regulator of p53, has been suggested to affect cancer predisposition and age of onset, primarily in females. However, findings ha ... ...
TechniScan, Inc. (OTC Bulletin Board: TSNI) ("TechniScan" or the "Company"), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, announced that it has commenced phase two of ... ...
What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma... ... ...
The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer. TGen Drug Development (TD2) will manage this pilot study for the Side-Ou ... ...